Clinical trial
RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and…
NCT00247325 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00247325 |
|---|---|
| Title | RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary Angiography |
| Official title | Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study, A Randomized Controlled Trial |
| Lead sponsor | Seoul National University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Drug |
| Interventions | Iodixanol(Drug) |
| Start date | Jan 1, 2004 |
| Completion | Dec 1, 2004 |
| First posted | Nov 1, 2005 |
| Last update posted | Nov 30, 2006 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: